Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
...
Health Technology » Medical Specialties
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| TMO | Thermo Fisher Scientific, Inc. | 0.31% | 610.12 | 1.0% | $825.30m | |
| DHR | Danaher Corp. | -0.21% | 324.36 | 0.7% | $642.83m | |
| ABT | Abbott Laboratories | -0.77% | 124.34 | 0.8% | $542.57m | |
| ISRG | Intuitive Surgical, Inc. | -0.15% | 1043.33 | 2.3% | $528.28m | |
| MDT | Medtronic Plc | -0.41% | 130.11 | 0.6% | $463.90m | |
| BDX | Becton, Dickinson & Co. | -0.21% | 253.28 | 1.0% | $354.78m | |
| ALGN | Align Technology, Inc. | -0.26% | 725.24 | 6.3% | $347.10m | |
| BAX | Baxter International, Inc. | 0.12% | 80.89 | 1.8% | $318.77m | |
| IDXX | IDEXX Laboratories, Inc. | -0.43% | 679.64 | 3.8% | $308.74m | |
| DXCM | DexCom, Inc. | -2.09% | 560.74 | 7.8% | $295.30m | |
| HRC | Hill-Rom Holdings, Inc. | -0.27% | 149.96 | 2.2% | $293.62m | |
| SYK | Stryker Corp. | 0.23% | 276.80 | 1.3% | $282.69m | |
| BSX | Boston Scientific Corp. | -0.76% | 44.66 | 1.0% | $258.58m | |
| ZBH | Zimmer Biomet Holdings, Inc. | 0.45% | 151.07 | 1.7% | $237.68m | |
| A | Agilent Technologies, Inc. | -0.26% | 172.32 | 1.6% | $230.65m |
Company Profile
Medtronic Plc is a medical technology company, which engages in the development, manufacture, distribution, and sale of device-based medical therapies and services. It operates through the following segments: Cardiac and Vascular Group; Minimally Invasive Technologies Group; Restorative Therapies Group; and Diabetes Group. The Cardiac and Vascular Group segment consists of products for the diagnosis, treatment, and management of cardiac rhythm disorders and cardiovascular disease. The Minimally Invasive Technologies Group segment focuses on respiratory system, gastrointestinal tract, renal system, lungs, pelvic region, kidneys, and obesity diseases. The Restorative Therapies Group segment comprises of neurostimulation therapies and drug delivery systems for the treatment of chronic pain, as well as areas of the spine and brain, along with pelvic health and conditions of the ear, nose, and throat. The Diabetes Group segment offers insulin pumps, coninuous glucose monitoring systems, and insulin pump consumables. The company was founded in 1949 and is headquartered in Dublin, Ireland.